Enterosorbent Tablet Sorption Capacity and Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing enterosorbents for digestive disorders face issues such as causing dyspeptic events, constipation, and allergic reactions due to lignin hydrolised content, and have manufacturing processes that are time and energy intensive, with delayed drug effects and stability issues during storage and transportation.
Innovation Solution
A tablet-based enterosorbent formulation using silicon dioxide, microcrystalline cellulose, sorbitol, croscarmellose sodium, and magnesium stearate in specific weight percentages, which replaces sugar with sorbitol to enhance decomposition, sorption capacity, and manufacturing efficiency, while maintaining color and consistency stability under extreme conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If sugar is used as a wetting agent in tablet manufacturing, then the tablet can be produced, but the manufacturing process becomes time-consuming and energy-intensive, and the enterosorbent decomposition is delayed
Solution Approach 1:
The patent changes the chemical composition parameter by replacing sugar with sorbitol as the wetting agent. This substitution alters the decomposition characteristics and manufacturing efficiency of the enterosorbent tablet, resolving the contradiction between ease of manufacture and time loss.
2Quantity of substance
If lignin hydrolised is included in the enterosorbent composition, then the adsorption capacity is enhanced, but dyspeptic events, constipation and allergic reactions occur
Solution Approach 1:
The patent removes lignin hydrolised from the enterosorbent composition while maintaining adequate adsorption capacity through alternative components. This extraction eliminates the harmful effects (dyspeptic events, constipation, allergic reactions) while preserving the essential function of the enterosorbent.
3Reliability
If tablets are stored under high temperature and humidity conditions, then storage stability is tested, but color changes to light yellow or light brown and consistency becomes friable
Solution Approach 1:
The patent modifies the composition parameters by replacing sugar with sorbitol and adjusting the ratio of microcrystalline cellulose to starch. These parameter changes enhance the tablet's resistance to color changes and consistency degradation under high temperature and humidity storage conditions.
4Duration of action of moving object
If the enterosorbent decomposes easily in the body, then the drug effect is faster, but the manufacturing process becomes more complex
Solution Approach 1:
The patent changes the compositional parameters by selecting specific ratios of microcrystalline cellulose (15-33 wt.%) and starch (2-6 wt.%), which optimize both decomposition rate and manufacturing simplicity. This resolves the contradiction between fast drug effect and manufacturing complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The enterosorbent maintains color and consistency stability during storage and transportation, improves organoleptic properties, and increases sorption capacity by 10-15%, making it safer for diabetic patients and more effective in promoting intestinal flora and vitamin synthesis.
Implementation Method 1
silicon dioxide colloidal 27,00-33,00... high adsorption capacity, including protein-binding activity
Implementation Method 2
a substance which serves for preparing a wetting agent in manufacturing tablets... sorbitol in amount of 20 to 30% by weight
Implementation Method 3
croscarmellose sodium 12,47-15,25... easily decomposes in the body
Data Source
AI summary
The enterosorbent in the form of a tablet contains the following components, wt.%: silicon dioxide colloidal 25,00 - 35,00 microcrystalline cellulose 15,00 - 33,00 sorbite 20,00 - 30,00 croscarmellose sodium 12,00 - 16,00 potato starch 2,00 - 6,00 magnesium stearate 0,50 - 1,10.